|
000
| 00798nam##2200217za#4500 |
|---|
| 001 | 9.694422 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624234117 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407|2011||||xxc|||||o f|0| 0 eng|d |
|---|
| 020 | |a978-1-100-18267-4 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-138/2011E-PDF |
|---|
| 110 | 1 |aCanada. |bHealth Canada. |
|---|
| 245 | 14|aThe Canadian Adverse Reaction Newsletter : |h[electronic resource]|bkeeping health professionals informed |
|---|
| 260 | |aOttawa - Ontario : |bHealth Canada |c[2011]. |
|---|
| 300 | |a1p. |
|---|
| 590 | |a11-23|b2011-06-10 |
|---|
| 775 | 08|tLe Bulletin canadien des effets indésirables : |w(CaOODSP)9.638597 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s627 KB|uhttps://publications.gc.ca/collections/collection_2011/sc-hc/H164-138-2011-eng.pdf |
|---|